DrugPatentWatch Database Preview
Aaa Usa Inc Company Profile
What is the competitive landscape for AAA USA INC, and when can generic versions of AAA USA INC drugs launch?
AAA USA INC has two approved drugs.
There is one US patent protecting AAA USA INC drugs.
There are twenty-three patent family members on AAA USA INC drugs in eighteen countries.
Summary for Aaa Usa Inc
| International Patents: | 23 |
| US Patents: | 1 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Aaa Usa Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aaa Usa Inc | LUTATHERA | lutetium dotatate lu-177 | SOLUTION;INTRAVENOUS | 208700-001 | Jan 26, 2018 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Aaa Usa Inc | NETSPOT | gallium dotatate ga-68 | POWDER;INTRAVENOUS | 208547-001 | Jun 1, 2016 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Aaa Usa Inc | NETSPOT | gallium dotatate ga-68 | POWDER;INTRAVENOUS | 208547-001 | Jun 1, 2016 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Aaa Usa Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| New Zealand | 622071 | Start Trial |
| Portugal | 2742017 | Start Trial |
| Mexico | 2014001691 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
